4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Orchestra BioMed Holdings, Inc. (OBIO) operates in the Biotechnology industry and is headquartered in New Hope, United States with about 86 employees. Its market capitalization is roughly $222 million. In the fiscal year ended 2025-12-31, OBIO reported $34M in revenue and ($53M) in net income.
Orchestra BioMed Holdings, Inc. operates as a biomedical company in the United States.
Interactive charts & full statements → Open the OBIO valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $34M | $3M | $3M | $4M | — |
| Gross Profit | $33M | $2M | $3M | $3M | — |
| Operating Income (EBIT) | ($52M) | ($64M) | ($52M) | ($33M) | — |
| Net Income | ($53M) | ($61M) | ($49M) | ($34M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $0M | $31M | $1M | $1M | $1M | — |
| Gross Profit | $0M | $31M | $1M | $1M | $1M | — |
| Operating Income (EBIT) | ($22M) | $7M | ($20M) | ($19M) | ($19M) | — |
| Net Income | ($21M) | $6M | ($21M) | ($19M) | ($19M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $115M | $76M | $95M | $96M | — |
| Total Liabilities | $61M | $43M | $27M | $43M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive OBIO viewer.
About TickerBase · Data methodology & sources